Sign In
Buy BCS
Barclays Earnings Calls
| Release date | Oct 22, 2025 |
| EPS estimate | $0.540 |
| EPS actual | $0.560 |
| EPS Surprise | 3.70% |
| Revenue estimate | 9.293B |
| Revenue actual | 9.643B |
| Revenue Surprise | 3.77% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.500 |
| EPS actual | $0.620 |
| EPS Surprise | 24.00% |
| Revenue estimate | 9.375B |
| Revenue actual | 25.114B |
| Revenue Surprise | 167.87% |
| Release date | Apr 30, 2025 |
| EPS estimate | $0.610 |
| EPS actual | $0.650 |
| EPS Surprise | 6.56% |
| Revenue estimate | 9.307B |
| Revenue actual | 9.953B |
| Revenue Surprise | 6.94% |
| Release date | Feb 13, 2025 |
| EPS estimate | $0.190 |
| EPS actual | $0.340 |
| EPS Surprise | 78.95% |
| Revenue estimate | 9.168B |
| Revenue actual | 7.128B |
| Revenue Surprise | -22.25% |
Last 4 Quarters for Barclays
Below you can see how BCS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 13, 2025 |
| Price on release | $14.54 |
| EPS estimate | $0.190 |
| EPS actual | $0.340 |
| EPS surprise | 78.95% |
| Date | Price |
|---|---|
| Feb 07, 2025 | $15.07 |
| Feb 10, 2025 | $14.98 |
| Feb 11, 2025 | $15.23 |
| Feb 12, 2025 | $15.39 |
| Feb 13, 2025 | $14.54 |
| Feb 14, 2025 | $14.88 |
| Feb 18, 2025 | $15.65 |
| Feb 19, 2025 | $15.37 |
| Feb 20, 2025 | $15.17 |
| 4 days before | -3.52% |
| 4 days after | 4.33% |
| On release day | 2.34% |
| Change in period | 0.664% |
| Release date | Apr 30, 2025 |
| Price on release | $16.06 |
| EPS estimate | $0.610 |
| EPS actual | $0.650 |
| EPS surprise | 6.56% |
| Date | Price |
|---|---|
| Apr 24, 2025 | $15.63 |
| Apr 25, 2025 | $15.82 |
| Apr 28, 2025 | $15.97 |
| Apr 29, 2025 | $16.13 |
| Apr 30, 2025 | $16.06 |
| May 01, 2025 | $15.82 |
| May 02, 2025 | $16.25 |
| May 05, 2025 | $16.38 |
| May 06, 2025 | $16.11 |
| 4 days before | 2.75% |
| 4 days after | 0.311% |
| On release day | -1.49% |
| Change in period | 3.07% |
| Release date | Jul 29, 2025 |
| Price on release | $20.05 |
| EPS estimate | $0.500 |
| EPS actual | $0.620 |
| EPS surprise | 24.00% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $19.46 |
| Jul 24, 2025 | $19.40 |
| Jul 25, 2025 | $19.62 |
| Jul 28, 2025 | $19.41 |
| Jul 29, 2025 | $20.05 |
| Jul 30, 2025 | $19.86 |
| Jul 31, 2025 | $19.62 |
| Aug 01, 2025 | $19.10 |
| Aug 04, 2025 | $19.32 |
| 4 days before | 3.03% |
| 4 days after | -3.64% |
| On release day | -0.95% |
| Change in period | -0.719% |
| Release date | Oct 22, 2025 |
| Price on release | $20.35 |
| EPS estimate | $0.540 |
| EPS actual | $0.560 |
| EPS surprise | 3.70% |
| Date | Price |
|---|---|
| Oct 16, 2025 | $19.95 |
| Oct 17, 2025 | $19.36 |
| Oct 20, 2025 | $19.62 |
| Oct 21, 2025 | $19.49 |
| Oct 22, 2025 | $20.35 |
| Oct 23, 2025 | $20.61 |
| Oct 24, 2025 | $20.68 |
| Oct 27, 2025 | $21.27 |
| Oct 28, 2025 | $21.57 |
| 4 days before | 2.01% |
| 4 days after | 6.00% |
| On release day | 1.28% |
| Change in period | 8.12% |
Barclays Earnings Call Transcript Summary of Q3 2025
Barclays reported strong Q3 2025 results and reiterated momentum in its 3-year transformation plan. Group income rose 11% year‑on‑year to GBP 7.2bn, TNAV per share increased to 392p, and quarterly RoTE was 10.6% (12.3% year‑to‑date). Management upgraded 2025 RoTE guidance to >11% and reaffirmed the 2026 target of >12%. They raised group NII guidance for 2025 to >GBP 12.6bn driven by UK lending momentum, operational progress in the U.S. Consumer Bank (USCB) and favourable reinvestment of the structural hedge. Barclays announced a GBP 500m buyback (pro‑forma CET1 13.9%) and plans quarterly buyback announcements subject to approvals. Costs included a GBP 235m motor finance provision; however, gross efficiency savings of ~GBP 500m for 2025 were achieved one quarter early and ~GBP 1.5bn of the GBP 2bn 2026 target have been delivered. Impairments were within guidance (loan loss rate 57bps including one-offs; 52bps excluding GM day‑1), with U.S. consumer delinquencies broadly stable. Divisions showed double‑digit RoTEs; Barclays UK, UK Corporate, Private Bank & Wealth, Investment Bank and USCB all improved. Management emphasized disciplined capital allocation, continued RWA growth in high‑return UK businesses, and plans to provide updated targets to 2028 at the February strategy update.
